Percutaneous mitral annular reduction provides continued benefit in an ovine model of dilated cardiomyopathy

Article

关键词: BRAIN NATRIURETIC PEPTIDE;    HEART-FAILURE;    CONTRACTILE FUNCTION;    REGURGITATION;    PERFORMANCE;    PLASMA;    DETERMINANT;    DYSFUNCTION;    EXPRESSION;    RESPONSES;   

DOI  :  10.1161/01.CIR.0000146904.13677.E4

来源: SCIE

【 摘 要 】

Background-Functional mitral valve regurgitation plays a key role in the symptomatic severity and progression of heart failure. In an ovine model of dilated cardiomyopathy, we examined the chronic functional consequences of mitral regurgitation reduction using a recently developed novel percutaneous mitral annular reduction (PMAR) device. Methods and Results-Fourteen adult sheep were paced right ventricularly at 180 to 190 bpm for 5 weeks, leading to the development of moderate mitral valve regurgitation. After echocardiographic, hemodynamic, and neurohormonal analysis, 9 animals underwent PMAR. All animals were subsequently paced for another 28 days, and a final echocardiographic and hemodynamic study was conducted. Animals that had undergone PMAR showed significantly increased negative and positive dP/dt, whereas pulmonary capillary wedge pressure and mitral valve regurgitation were significantly reduced compared with those at device implant despite continued pacing. In conjunction, significant improvements in plasma norepinephrine and brain natriuretic peptide were apparent. Conclusions-The application of PMAR in animals with pacing-induced dilated cardiomyopathy and functional mitral valve regurgitation resulted in continued improvements in hemodynamic and neurohormonal parameters.

【 授权许可】

Free